Logo image of DAN

DANA INC (DAN) Stock Fundamental Analysis

NYSE:DAN - New York Stock Exchange, Inc. - US2358252052 - Common Stock - Currency: USD

16.85  -0.4 (-2.32%)

After market: 16.85 0 (0%)

Fundamental Rating

2

Overall DAN gets a fundamental rating of 2 out of 10. We evaluated DAN against 80 industry peers in the Automobile Components industry. Both the profitability and financial health of DAN have multiple concerns. DAN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year DAN was profitable.
DAN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DAN reported negative net income in multiple years.
In the past 5 years DAN always reported a positive cash flow from operatings.
DAN Yearly Net Income VS EBIT VS OCF VS FCFDAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.45%, DAN is doing worse than 75.00% of the companies in the same industry.
With a Return On Equity value of -2.54%, DAN is not doing good in the industry: 73.75% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 4.95%, DAN is not doing good in the industry: 78.75% of the companies in the same industry are doing better.
DAN had an Average Return On Invested Capital over the past 3 years of 5.02%. This is below the industry average of 9.12%.
Industry RankSector Rank
ROA -0.45%
ROE -2.54%
ROIC 4.95%
ROA(3y)-1.18%
ROA(5y)-0.27%
ROE(3y)-5.82%
ROE(5y)-1.8%
ROIC(3y)5.02%
ROIC(5y)4.73%
DAN Yearly ROA, ROE, ROICDAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

The Operating Margin of DAN (3.23%) is worse than 78.75% of its industry peers.
DAN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 8.61%, DAN is doing worse than 88.75% of the companies in the same industry.
In the last couple of years the Gross Margin of DAN has declined.
Industry RankSector Rank
OM 3.23%
PM (TTM) N/A
GM 8.61%
OM growth 3Y-8.06%
OM growth 5Y-14.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-8.28%
DAN Yearly Profit, Operating, Gross MarginsDAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1

2. Health

2.1 Basic Checks

DAN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DAN has been increased compared to 1 year ago.
The number of shares outstanding for DAN has been increased compared to 5 years ago.
Compared to 1 year ago, DAN has a worse debt to assets ratio.
DAN Yearly Shares OutstandingDAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
DAN Yearly Total Debt VS Total AssetsDAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

DAN has an Altman-Z score of 1.86. This is not the best score and indicates that DAN is in the grey zone with still only limited risk for bankruptcy at the moment.
DAN's Altman-Z score of 1.86 is on the low side compared to the rest of the industry. DAN is outperformed by 78.75% of its industry peers.
DAN has a debt to FCF ratio of 21.33. This is a negative value and a sign of low solvency as DAN would need 21.33 years to pay back of all of its debts.
DAN has a Debt to FCF ratio of 21.33. This is in the lower half of the industry: DAN underperforms 75.00% of its industry peers.
A Debt/Equity ratio of 1.85 is on the high side and indicates that DAN has dependencies on debt financing.
DAN has a Debt to Equity ratio of 1.85. This is amonst the worse of the industry: DAN underperforms 91.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.85
Debt/FCF 21.33
Altman-Z 1.86
ROIC/WACC0.54
WACC9.22%
DAN Yearly LT Debt VS Equity VS FCFDAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

DAN has a Current Ratio of 1.43. This is a normal value and indicates that DAN is financially healthy and should not expect problems in meeting its short term obligations.
DAN has a Current ratio of 1.43. This is amonst the worse of the industry: DAN underperforms 83.75% of its industry peers.
DAN has a Quick Ratio of 1.43. This is a bad value and indicates that DAN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DAN (0.85) is worse than 86.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.85
DAN Yearly Current Assets VS Current LiabilitesDAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

DAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
DAN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.71% yearly.
DAN shows a decrease in Revenue. In the last year, the revenue decreased by -7.00%.
DAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.59% yearly.
EPS 1Y (TTM)0%
EPS 3Y-18.46%
EPS 5Y-21.71%
EPS Q2Q%-40.91%
Revenue 1Y (TTM)-7%
Revenue growth 3Y4.76%
Revenue growth 5Y3.59%
Sales Q2Q%-14%

3.2 Future

The Earnings Per Share is expected to grow by 28.77% on average over the next years. This is a very strong growth
DAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.50% yearly.
EPS Next Y57.78%
EPS Next 2Y47.02%
EPS Next 3Y36.44%
EPS Next 5Y28.77%
Revenue Next Year-5.79%
Revenue Next 2Y-3.9%
Revenue Next 3Y-2.18%
Revenue Next 5Y1.5%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DAN Yearly Revenue VS EstimatesDAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
DAN Yearly EPS VS EstimatesDAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.80 indicates a rather expensive valuation of DAN.
DAN's Price/Earnings is on the same level as the industry average.
DAN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.66, the valuation of DAN can be described as very reasonable.
62.50% of the companies in the same industry are more expensive than DAN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.76. DAN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 20.8
Fwd PE 8.66
DAN Price Earnings VS Forward Price EarningsDAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

DAN's Enterprise Value to EBITDA ratio is in line with the industry average.
DAN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 18.89
EV/EBITDA 6.23
DAN Per share dataDAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DAN's earnings are expected to grow with 36.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y47.02%
EPS Next 3Y36.44%

3

5. Dividend

5.1 Amount

DAN has a Yearly Dividend Yield of 2.32%. Purely for dividend investing, there may be better candidates out there.
DAN's Dividend Yield is comparable with the industry average which is at 4.21.
DAN's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

The dividend of DAN decreases each year by -0.02%.
DAN has paid a dividend for at least 10 years, which is a reliable track record.
DAN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-0.02%
Div Incr Years0
Div Non Decr Years4
DAN Yearly Dividends per shareDAN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

DAN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-165.71%
EPS Next 2Y47.02%
EPS Next 3Y36.44%
DAN Yearly Income VS Free CF VS DividendDAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

DANA INC

NYSE:DAN (7/11/2025, 8:04:00 PM)

After market: 16.85 0 (0%)

16.85

-0.4 (-2.32%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners106.72%
Inst Owner Change-0.01%
Ins Owners0.44%
Ins Owner Change9.2%
Market Cap2.46B
Analysts73.85
Price Target22.1 (31.16%)
Short Float %4.17%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly Dividend0.4
Dividend Growth(5Y)-0.02%
DP-165.71%
Div Incr Years0
Div Non Decr Years4
Ex-Date05-09 2025-05-09 (0.1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)51.52%
Min EPS beat(2)-21.99%
Max EPS beat(2)125.02%
EPS beat(4)2
Avg EPS beat(4)16.62%
Min EPS beat(4)-47.77%
Max EPS beat(4)125.02%
EPS beat(8)5
Avg EPS beat(8)36.01%
EPS beat(12)7
Avg EPS beat(12)19.66%
EPS beat(16)9
Avg EPS beat(16)10.37%
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.89%
Max Revenue beat(2)1.34%
Revenue beat(4)1
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.62%
Revenue beat(12)6
Avg Revenue beat(12)-0.43%
Revenue beat(16)10
Avg Revenue beat(16)1.07%
PT rev (1m)11.11%
PT rev (3m)8.33%
EPS NQ rev (1m)-1.41%
EPS NQ rev (3m)1.45%
EPS NY rev (1m)7.06%
EPS NY rev (3m)-6.45%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)2.2%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)1.1%
Valuation
Industry RankSector Rank
PE 20.8
Fwd PE 8.66
P/S 0.25
P/FCF 18.89
P/OCF 4.77
P/B 1.78
P/tB 2.52
EV/EBITDA 6.23
EPS(TTM)0.81
EY4.81%
EPS(NY)1.95
Fwd EY11.54%
FCF(TTM)0.89
FCFY5.29%
OCF(TTM)3.53
OCFY20.97%
SpS67.94
BVpS9.46
TBVpS6.68
PEG (NY)0.36
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.45%
ROE -2.54%
ROCE 6.44%
ROIC 4.95%
ROICexc 5.5%
ROICexgc 6.03%
OM 3.23%
PM (TTM) N/A
GM 8.61%
FCFM 1.31%
ROA(3y)-1.18%
ROA(5y)-0.27%
ROE(3y)-5.82%
ROE(5y)-1.8%
ROIC(3y)5.02%
ROIC(5y)4.73%
ROICexc(3y)5.54%
ROICexc(5y)5.19%
ROICexgc(3y)6.12%
ROICexgc(5y)5.83%
ROCE(3y)6.38%
ROCE(5y)6.02%
ROICexcg growth 3Y-0.28%
ROICexcg growth 5Y-11.5%
ROICexc growth 3Y1.52%
ROICexc growth 5Y-10.28%
OM growth 3Y-8.06%
OM growth 5Y-14.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-8.28%
F-Score4
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.85
Debt/FCF 21.33
Debt/EBITDA 3.47
Cap/Depr 92.33%
Cap/Sales 3.89%
Interest Coverage 250
Cash Conversion 69.88%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.85
Altman-Z 1.86
F-Score4
WACC9.22%
ROIC/WACC0.54
Cap/Depr(3y)107.96%
Cap/Depr(5y)101.61%
Cap/Sales(3y)4.26%
Cap/Sales(5y)4.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-18.46%
EPS 5Y-21.71%
EPS Q2Q%-40.91%
EPS Next Y57.78%
EPS Next 2Y47.02%
EPS Next 3Y36.44%
EPS Next 5Y28.77%
Revenue 1Y (TTM)-7%
Revenue growth 3Y4.76%
Revenue growth 5Y3.59%
Sales Q2Q%-14%
Revenue Next Year-5.79%
Revenue Next 2Y-3.9%
Revenue Next 3Y-2.18%
Revenue Next 5Y1.5%
EBIT growth 1Y-14.89%
EBIT growth 3Y-3.68%
EBIT growth 5Y-11.9%
EBIT Next Year115.65%
EBIT Next 3Y34.36%
EBIT Next 5Y28.72%
FCF growth 1Y-16.67%
FCF growth 3YN/A
FCF growth 5Y-19.8%
OCF growth 1Y-14.17%
OCF growth 3Y41.75%
OCF growth 5Y-6.71%